Cargando…
Obatoclax, a Pan-BCL-2 Inhibitor, Targets Cyclin D1 for Degradation to Induce Antiproliferation in Human Colorectal Carcinoma Cells
Colorectal cancer is the third most common cancer worldwide. Aberrant overexpression of antiapoptotic BCL-2 (B-cell lymphoma 2) family proteins is closely linked to tumorigenesis and poor prognosis in colorectal cancer. Obatoclax is an inhibitor targeting all antiapoptotic BCL-2 proteins. A previous...
Autores principales: | Or, Chi-Hung R., Chang, Yachu, Lin, Wei-Cheng, Lee, Wee-Chyan, Su, Hong-Lin, Cheung, Muk-Wing, Huang, Chang-Po, Ho, Cheesang, Chang, Chia-Che |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297679/ https://www.ncbi.nlm.nih.gov/pubmed/28035994 http://dx.doi.org/10.3390/ijms18010044 |
Ejemplares similares
-
Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling
por: Or, Chi-Hung R., et al.
Publicado: (2020) -
Potential utility of the pan-Bcl-2 inhibitor GX15–070 (obatoclax) in cancer immunotherapy
por: Kim, Peter S, et al.
Publicado: (2014) -
The pan-Bcl-2 inhibitor obatoclax promotes differentiation and apoptosis of acute myeloid leukemia cells
por: Opydo-Chanek, Małgorzata, et al.
Publicado: (2020) -
Pan-Bcl-2 Inhibitor Obatoclax Delays Cell Cycle Progression and Blocks Migration of Colorectal Cancer Cells
por: Koehler, Bruno Christian, et al.
Publicado: (2014) -
Cryptocaryone Promotes ROS-Dependent Antiproliferation and Apoptosis in Ovarian Cancer Cells
por: Chen, Yu-Chieh, et al.
Publicado: (2022)